Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Biomarkers for Diagnosis and Prognosis in Vascular Cognitive Impairment

NCT04604600 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04604600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04604600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Biomarkers for Diagnosis and Prognosis in Vascular Cognitive Impairment
Lead sponsor
National Taiwan University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
September 3, 2020
Completion date
July 31, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, vascular cognitive impairment